October 21, 2022
Enhertu's FDA approval marked a major milestone in the breast cancer space, as it was the first drug to be approved for patients with HER2-low disease.
October 20, 2022
It is essential that patients with breast cancer speak up to their health care providers, be it advocating for genetic testing or discussing symptoms.
October 19, 2022
Chest numbness following a mastectomy can be truly daunting, but patients with breast cancer don’t have to suffer in silence — and it may not be something they have to live with.
October 18, 2022
An FDA approval put Ki-67 scoring — which may predict tumor growth — in the spotlight, but what that means long term to patients depends on who you ask.
October 17, 2022
There are ways to manage the fear of cancer recurrence, so it doesn’t become overwhelming or debilitating. Physicians like me and a network of resources are here to help.
October 11, 2022
The designation of HER2-low status is rapidly reshaping how researchers and care providers not only think about, but also treat, breast cancer.